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Abstract
Measles remains a significant childhood disease, and is associated with a transient immune suppression. Paradoxically,
measles virus (MV) infection also induces robust MV-specific immune responses. Current hypotheses for the mechanism
underlying measles immune suppression focus on functional impairment of lymphocytes or antigen-presenting cells,
caused by infection with or exposure to MV. We have generated stable recombinant MVs that express enhanced green
fluorescent protein, and remain virulent in non-human primates. By performing a comprehensive study of virological,
immunological, hematological and histopathological observations made in animals euthanized at different time points after
MV infection, we developed a model explaining measles immune suppression which fits with the ‘‘measles paradox’’. Here
we show that MV preferentially infects CD45RA2 memory T-lymphocytes and follicular B-lymphocytes, resulting in high
infection levels in these populations. After the peak of viremia MV-infected lymphocytes were cleared within days, followed
by immune activation and lymph node enlargement. During this period tuberculin-specific T-lymphocyte responses
disappeared, whilst strong MV-specific T-lymphocyte responses emerged. Histopathological analysis of lymphoid tissues
showed lymphocyte depletion in the B- and T-cell areas in the absence of apoptotic cells, paralleled by infiltration of T-
lymphocytes into B-cell follicles and reappearance of proliferating cells. Our findings indicate an immune-mediated
clearance of MV-infected CD45RA2 memory T-lymphocytes and follicular B-lymphocytes, which causes temporary
immunological amnesia. The rapid oligoclonal expansion of MV-specific lymphocytes and bystander cells masks this
depletion, explaining the short duration of measles lymphopenia yet long duration of immune suppression.
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Introduction
Measles is associated with a transient but profound immune
suppression, which may last for several weeks to months after the
acute stage of the disease. The clinical importance of this immune
suppression is illustrated by the observation that measles mortality is
typically caused by secondary infections in the respiratory or
digestive tract [1–3]. However, the mechanism by which measles
virus (MV) infection causes immune suppression is not completely
understood. Multiple in vivo correlates of immune suppression have
been described, including disappearance of Mantoux responses
[4,5], lymphopenia [6,7] and impaired responses to vaccination
[8,9]. Decreased lymphoproliferative responses [10,11], altered
cytokine response profiles [12] and impairment of antigen-
presenting cell function [13–15] have been described in vitro. The
relevance of these observations to immune suppression and
enhanced susceptibility to opportunistic infections remains unclear.
The paradox of measles is that the acute phase of the disease is not
only associated with immune suppression, but also with immune
activation [16] and induction of robust MV-specific humoral and
cellular immune responses that result in lifelong immunity.
MV infection is initiated in the respiratory tract. It has long
been thought that the initial target cells of the virus were epithelial
cells of the upper respiratory tract, but recent studies have
demonstrated a major role for alveolar macrophages and dendritic
cells (DC) in this process [17,18]. These first MV-infected cells
transmit the virus to the bronchus-associated lymphoid tissue
(BALT) and/or the draining lymph nodes, where the infection is
further amplified in lymphocytes and viremia is initiated [18,19].
MV infects both T- and B-lymphocytes by binding of the MV-
hemagglutinin (H) glycoprotein to the cellular receptor CD150
[20]. Recently, the adherens junction protein PVRL4 was
identified as cellular receptor on epithelial cells [21,22]. However,
as this receptor is exclusively expressed on the basolateral surface
of epithelial cells, it does not facilitate MV infection of epithelial
cells during the early stages of the disease, but instead is thought to
play a role in transmission during the late stages of measles
pathogenesis [23].
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It has been proposed that direct infection of lymphocytes and
the subsequent lymphopenia could explain measles-associated
immune suppression [24,25]. However, this hypothesis has often
been dismissed based on the observation that lymphopenia only
lasts about a week, whilst immune suppression persists for several
weeks to months. In addition, during the peak of viremia no more
than 1 to 5% of the total lymphocyte population in peripheral
blood is infected [26,27]. Recent observations that MV infects
high percentages of cells in lymphoid tissues [27] and preferen-
tially targets CD45RA2 or CD45R0+ memory T-lymphocytes
[27,28] led us to revisit the lymphocyte depletion hypothesis for
immune suppression using the macaque model. Analysis of
virological, immunological and histopathological parameters has
demonstrated a remarkable similarity between measles in
macaques and humans [29]. Here we present a comprehensive
overview of a number of in vivo studies performed in macaques
which provides a unifying model for the etiology of measles
immune suppression that is both compatible with the measles
paradox and with historical in vitro and in vivo correlates of measles
immune suppression.
Results
MV targets lymphoid tissues and preferentially infects
CD45RA2 memory T-lymphocytes
We have analyzed data from rhesus or cynomolgus macaques
(n = 40) infected with recombinant (r) MV strains (rMVIC323 or
rMVKS) expressing enhanced green fluorescent protein (EGFP),
spanning the early, intermediate and late stages of MV infection
(Table S1). Data from previous studies [18,27,30] and from
additional experimentally infected macaques (n = 14) were com-
bined. The rMVs expressed EGFP from an additional transcrip-
tion unit, and MV replication results in the host cell becoming
EGFP+. At the peak of viremia, EGFP fluorescence was
macroscopically detected in all lymphoid tissues (Figure 1A–D).
The percentages MV-infected cells in lymphocyte subsets in
PBMC or lymphoid tissues collected 9 or 11 days post-infection
(d.p.i.) were determined by flow cytometry. Lymphocytes were
subtyped as CD4+ or CD8+ naive (CD45RA+, Tn), central
memory (CD45RA2CCR7+, TCM) or effector memory
(CD45RA2CCR72, TEM) T-lymphocytes or as naive
(IgD+CD272, Bn) or memory (IgD2CD27+, BM) CD20+HLA-
DR+ B-lymphocytes (Figure S1). TCM and TEM were infected at a
significantly higher level than Tn. In contrast, BM were not
preferentially infected (Figure 1E–H).
To determine whether the increased susceptibility of CD45RA2
memory T-lymphocytes (TM) to MV infection is an inherent
property of these cells, and comparable between humans and
macaques, we sorted naive and memory CD4+ and CD8+ T-
lymphocyte populations from human or macaque PBMC on basis
of CD45A expression. In vitro co-culture of these populations with
MV-infected autologous cells showed that both human and
macaque CD45RA2 TM were preferentially infected by MV
(Figure 2A). In an alternative approach, unsorted human or
macaque PBMC were co-cultured with autologous MV-infected
cells, and infection percentages in Tn, TCM and TEM were
determined by flow cytometry, resulting in similar differences in
the susceptibility of T-lymphocyte subpopulations (Figure 2B).
This not only corroborated the in vivo results from the experimen-
tally infected macaques, but also demonstrated a virtually identical
trend for human and macaque subpopulations.
The MV receptor CD150 is expressed at high levels by
activated human CD45ROhigh memory T-lymphocytes [31]. We
determined the expression levels of CD150 on the different human
and macaque T-lymphocyte subsets. This confirmed the higher
level of CD150 expression by human CD45RA2 TCM and TEM
when compared to CD45RA+ Tn, and showed that the expression
levels of CD150 on human and macaque T-lymphocyte subsets
are comparable, which likely explains the increased susceptibility
of CD45RA2 TM to MV infection (Figure 2C–F). Although we
were unsuccessful in further subtyping B-lymphocyte subsets on
basis of expression patterns of different surface markers, the
observed efficient infection of both Bn and BM lymphocytes seems
in accordance with recent studies demonstrating CD150 expres-
sion on virtually all human B-lymphocyte subpopulations [32].
MV causes lymphocyte depletion in lymphoid tissues
To address the impact of MV infection in situ, immunohisto-
chemical analyses of serial sections of lymphoid tissues collected at
different d.p.i. were performed. This demonstrated that MV
mainly replicated in B-cell follicles (Figure 3; 7 and 9 d.p.i.), as
previously described [27,33]. Multiple syncytia were observed
9 d.p.i., and dual immunofluorescence showed these were of B-
lymphocyte origin (Figure S2). Strikingly similar to classic
observations in humans [34], lymphoid exhaustion of the centers
of the B-cell follicles was observed during and shortly after the
peak of viremia (Figure 3; 9 and 11 d.p.i.).
MV infection suppresses tuberculin-specific T-
lymphocyte responses
In vitro and in vivo recall T-lymphocyte responses to tuberculin
were measured in Bacille Calmette-Gue´rin (BCG)-vaccinated
macaques, prior to and 11 or 13 d.p.i. IFN-c production of
PBMC in response to purified-protein derivative (PPD) stimulation
was reduced after MV infection. Notably, an MV-specific IFN-c
response was detected in PBMC collected from macaques
sacrificed 13 d.p.i. (Figure 4A). The in vivo recall response was
determined by Mantoux testing. Before MV infection a charac-
teristic delayed-type hypersensitivity response developed on the
site of intra-dermal tuberculin injection, characterized by a well-
delineated soft swelling of the cutus, corresponding with an influx
of CD3+ T-lymphocytes (Figure 4B). In line with classical
observations [4,5], Mantoux responses were suppressed after
MV infection, with a much smaller and harder swelling in
the cutus, potentially corresponding with epidermal repair,
Author Summary
Measles is associated with a transient immune suppres-
sion, resulting in increased susceptibility to opportunistic
infections. Indeed, the main causes of measles mortality
are secondary infections in the respiratory and digestive
tract. Although measles is associated with lymphopenia,
depletion of lymphocytes has often been dismissed as a
cause of immune suppression. Lymphocyte counts rapidly
return to normal after clearance of the virus, while immune
suppression lasts several weeks to months. Many studies
have focused on suppression of lymphocyte proliferation
as an in vitro correlate of immune suppression. However,
experimental infections of non-human primates show that
in vivo lymphocyte proliferation is not impaired after
measles. Instead, we hypothesize that massive expansion
of MV-specific and bystander lymphocytes masks the fact
that pre-existing memory lymphocytes have been deplet-
ed. We conclude that measles virus infection wipes out
immunological memory, leaving individuals susceptible to
opportunistic infectious agents that would normally be
controlled by the immune system.
Measles Immune Suppression in Macaques
PLOS Pathogens | www.plospathogens.org 2 August 2012 | Volume 8 | Issue 8 | e1002885
skin-infiltrating CD3+ T-lymphocytes were absent (Figure 4B).
Interestingly, we also observed macroscopically detectable EGFP
expression in the skin at the sites where the animals had been
vaccinated intra-cutaneously with BCG three months prior to MV
infection (Figure S3), suggesting infection of tissue-resident
memory lymphocytes in the skin.
MV infection causes transient leukopenia followed by
massive lymphocyte expansion
Analysis of macaque white blood cell (WBC) counts during the
acute infection demonstrated a profound but transient leukopenia
(Figure 5B, circles), which coincided with the peak of viremia.
There was a relative decrease in size of the CD45RA2 CD4+ and
CD8+ TCM and TEM populations between 0 and 9 d.p.i.
(Figure 5A), suggesting that leukopenia was related to depletion
of MV-infected cells. WBC counts rapidly returned to pre-
infection levels between 9 and 15 d.p.i. (Figure 5B), paralleled by a
restoration of the relative CD45RA2 TCM and TEM population
sizes (Figure 5A). Lymph nodes were enlarged in all animals
euthanized between 11 and 15 d.p.i., which was paralleled by the
clearance of EGFP+ lymphocytes from lymphoid tissues. During
this period large numbers of Ki67+ proliferating cells repopulated
the B-cell follicles in the germinal centers of lymphoid tissues
(Figure 3; 13 and 15 d.p.i.). Numbers of apoptotic lymphocytes, as
detected by staining for cleaved caspase 3 (CC3), remained low at
all time-points (Figure S4). Infiltration of CD3+ T-lymphocytes
into the B-cell follicles suggests that MV-infected cells were cleared
by cytotoxic T-lymphocyte-mediated killing, rather than under-
going apoptosis [35].
A unified model for measles immune suppression
Based on the observations described above we propose a model
for the events leading to measles immune suppression. Infection and
subsequent immune-mediated clearance of CD150+ lymphocytes
Figure 1. MV infects high percentages of B-lymphocytes and CD45RA2memory T-lymphocytes. (A–D) Macroscopic detection of EGFP in
lymphoid tissues of the gastro-intestinal tract in three different macaques: mesenteric lymph nodes (A), gut-associated lymphoid tissue (GALT) (B and
C), including the Peyer’s patches (C and D). Panel D is an enlargement of panel C (indicated by asterisk); (E–H) MV infection percentages in
lymphocyte subsets during the approximate peak viremia. T-lymphocyte subpopulations were identified as Tn (CD45RA+), TCM (CD45RA2CCR7+) or
TEM (CD45RA2CCR72), B-lymphocytes were identified as Bn (CD272IgD+) or BM (CD27+IgD2). Box plots were chosen since the data were not normally
distributed, and show the median infection percentages with the 25th–75th percentiles, error bars indicate the 10th–90th percentiles, dots the 5th–95th
percentiles. The 10th–90th percentiles and 5th–95th percentiles are only shown if the number of observations is at least ten; **, P,0.01. *, P,0.05. In
panel E, F and G 14 animals were included; in panel H 3 animals were included.
doi:10.1371/journal.ppat.1002885.g001
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results in specific depletion of memory T-lymphocytes and follicular
B-lymphocytes, whilst the naive T-lymphocyte population remains
relatively unaffected (Figure 5B, populations shown in red and blue,
respectively). However, this leaves the question how such a short
duration of measles lymphopenia can be reconciled with the long-
lasting immune suppression. We hypothesize that the lymphocyte
depletion is masked by the massive expansion of MV-specific and
bystander lymphocytes (Figure 5B, population shown in green),
which has also been observed in humans by a massive expansion of
CD8+ T-lymphocytes [36] and by demonstrating skewing of the T-
cell receptor repertoire after measles [37]. As a consequence, the
qualitative composition of the lymphocyte population immediately
after recovery from lymphopenia is dramatically different from that
before MV infection, as pre-existing memory lymphocytes have
been depleted and replaced by MV-specific and bystander
lymphocytes. The net result is a temporary immunological amnesia,
and restoration of immunological memory may take several weeks.
Thus this model explains why measles-associated immune suppres-
sion extends well beyond the transient lymphopenia.
Discussion
Based on our observations, we conclude that measles immune
suppression can, at least in part, be explained by massive infection
and subsequent immune-mediated clearance of CD150+ memory T-
Figure 2. Susceptibility of human or macaque T-lymphocyte subsets to in vitro MV infection. (A) Human or macaque PBMC were sorted
into naive (CD45RA+, Tn) or memory (CD45RA2, TM) CD4+ or CD8+ T-lymphocytes, and infected with MV in vitro. Percentages MV-infected T-
lymphocytes were determined 2 d.p.i. by measuring EGFP fluorescence by flow cytometry. CD4+ (human and macaque) and CD8+ (human only) TM
were significantly more susceptible to MV infection than the corresponding Tn. For macaque CD8+ T-lymphocytes the difference was significant in
two out of three experiments; (B) Unsorted human and macaque PBMC were infected, MV infection percentages in the different T-lymphocyte
subsets were determined 2 d.p.i. by flow cytometry. Both in human and macaque PBMC the CD4+ and CD8+ TCM and TEM were significantly more
susceptible to MV infection than the corresponding Tn subpopulations. In addition, CD4+ TEM and, to a lesser extent, CD8+ TEM proved more
susceptible to MV infection than TCM. (C–F) Levels of CD150 expression on the different T-lymphocyte subsets in human and macaque PBMC. (C)
PBMC collected from human or macaque donors were stained for memory markers as described in Figure S1, in combination with an IgG1 isotype
control or CD150FITC staining. CD150 expression on the different subsets is shown as geometric mean fluorescence intensity (Gmean FI) 6 SD. Both
for humans and macaques CD150 expression on CD4+ and CD8+ TCM and TEM was significantly higher than on Tn. Interestingly, in CD4+ T-
lymphocytes CD150 expression was significantly higher on TEM than on TCM, whereas in CD8+ T-lymphocytes an inverse pattern was observed. (D–F)
An IgG1 isotype control was used to determine the level of background staining, and is shown in combination with the CD150 staining for each
subset. **, P,0.01. *, P,0.05. Experiments were performed with sorted cells from 3 macaque and 2 human donors, and unsorted cells from 4
macaque and 5 human donors. Data are shown as means 6 standard deviation (SD) of representative donors.
doi:10.1371/journal.ppat.1002885.g002
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lymphocytes and follicular B-lymphocytes. Depletion of T- and
B-lymphocytes has also been described in the BALT of measles
patients [38].We show thatMVpreferentially infects CD45RA2TCM
and TEM, which during secondary immune responses are the primary
source of T-lymphocyte expansion or generation of effector
T-lymphocytes, respectively [39]. Infection and subsequent immune-
mediated depletion of memory T-lymphocyte subsets fits with the first
description of measles-induced immune suppression, namely the
disappearance of Mantoux responses in measles patients [4].
Several hypotheses for the underlying mechanism of measles
immune suppression have been described previously. However,
none of these adequately explain the ‘‘measles paradox’’: the disease
is associated with immune suppression but also with induction of
strong MV-specific immune responses. Our observations not only
explain the measles paradox, but also shed light on many of the in
vivo and in vitro correlates of measles immune suppression described
in literature [40–42]. Unresponsiveness of PBMC to mitogens and
altered cytokine profiles during and after the acute phase of measles
have been demonstrated in vitro in several studies [10,11]. These
observations are not disputed, but we consider it difficult to
extrapolate unresponsiveness of PBMC to mitogens in vitro to
immune suppression in vivo. In parallel with the clearance of MV-
infected cells we observed high numbers of proliferating Ki67+ cells
in B-cell follicles. This fits well with classical observations of immune
activation following measles [16], suggesting that lymphoprolifer-
ation is not impaired in vivo during the convalescent phase. The
observed in vitro suppression of mitogen-induced lymphoprolifera-
tion could also be explained by the altered qualitative composition
Figure 3. Histology and immunohistochemistry of lymphoid tissues obtained from macaques euthanized between 5 and 15 d.p.i.
Serial sections were stained for histological changes (H&E), MV infection (EGFP), B-lymphocytes (CD20), T-lymphocytes (CD3) or proliferating cells
(Ki67). Multiple lymphoid tissues from multiple animals collected at each time-point were analyzed, panels shown are representative for the tissues
that have been examined. The color intensity of the blue bars below the photomicrographs indicates the relative levels of viremia, lymphocyte
depletion or proliferation. The green and red bars at the bottom indicate the appearance and disappearance of viremia and rash and correspond to
the bars in Figure 5B.
doi:10.1371/journal.ppat.1002885.g003
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of lymphocyte populations in convalescent measles patients,
compared to healthy controls. Our model and previously published
observations [16] show that a large proportion of the lymphocytes
that circulate during the first weeks after measles infection have
been recently activated in vivo, potentially making these cells less
susceptible to re-stimulation in vitro.
We do not exclude that a functional impairment of lymphocytes
or DC contributes to immune suppression and thus may augment
the extent of immune suppression. Actually, it is likely that there
are many factors that contribute to immune suppression in vivo. To
date, direct evidence of DC infection by MV in humans has not
been obtained. However, it has been demonstrated in vitro that MV
Figure 4. MV infection causes temporary immunological amnesia. (A) T-lymphocyte responses to PPD and MV were measured by IFN-c
production after in vitro stimulation of PBMC collected from 4 BCG-vaccinated macaques. Measurements were performed in triplicate, graphs shows
means 6 SD; (B) Mantoux tests were performed 7 days before (n = 4) and 8 (n = 2) or 10 (n = 2) days after MV infection. Images were collected 3 days
after intra-dermal injection with tuberculin. Before MV infection classical delayed-type hypersensitivity responses were observed, associated with
diffuse swelling and redness (indicated by arrows), after MV only a small localized papule was observed (indicated by arrow). H&E and CD3 staining of
the corresponding skin tissues showed infiltration of T-lymphocytes in the dermis of the pre-infection Mantoux response, which was absent after MV
infection. Representative images from 4 animals are shown.
doi:10.1371/journal.ppat.1002885.g004
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is capable of infecting mature DC and Langerhans cells (LC)
[13,14,43–47]. In vivo in experimentally MV-infected macaques
there was strong evidence for infection of DC in the skin and
secondary lymphoid tissues [27]. The role of DC in immune
suppression has not been extensively studied in vivo, but it is
possible that they play a role either by directly being targeted and
depleted by MV or indirectly by interaction with and silencing of
T-lymphocytes. Furthermore, the capacity to function as antigen
presenting cells might be affected [40,48].
Our study covers a time period of two weeks after MV infection,
and as such does not provide experimental proof of what happens
during resolution of measles immune suppression. The strength of
our model using recombinant EGFP-expressing MV mainly lies in
the sensitive detection of MV-infected cells, which is limited to the
first two weeks after MV infection. Clearly, the memory
lymphocyte populations specific for previously encountered
pathogens are not completely depleted, and are largely restored
during the weeks to months after measles. For instance, previously
positive Mantoux responses disappear after onset of rash [4,5], but
eventually reappear. We have indicated this in our model
(Figure 5B) by showing a gradual increase of the memory
lymphocyte population after clearance of MV. Although we
cannot fully explain the drivers of the resolution of immune
suppression, it is possible that expansion of non-depleted TCM
upon renewed antigen encounter may play an important role.
However, homeostatic restoration by the immune system itself
could be an alternative explanation.
Some of the individual observations described here have been
reported earlier in relationship to animal morbillivirus-related
immune suppression [49–51]. The novelty of our model lies in the
immune-mediated lymphodepletion being masked by the massive
expansion of MV-specific and bystander lymphocytes. Although
Figure 5. A model for measles immune suppression. (A) Relative population sizes of CD4+ or CD8+ Tn, TCM and TEM in PBMC at different d.p.i.,
expressed as fold changes relative to 0 d.p.i. Means 6 SEM of 9 animals are shown. (B). A model describing the changes in the relative size of pre-
existing naive lymphocytes (blue), pre-existing memory lymphocytes (red, sum of TM and follicular B-lymphocytes) and newly induced MV-specific
(and bystander) lymphocytes (green) before, during and after measles. The relative WBC counts obtained from the macaques included in this study
have been overlaid (black circles, means 6 SEM). Thirty-four animals were included to obtain the WBC count graph. The red line indicates the time-
point of MV-infection, bars above the graph indicate the approximate period of MV viremia (green), rash (red) and immune suppression (black).
doi:10.1371/journal.ppat.1002885.g005
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effective MV-specific CD8+ T-lymphocyte responses as well as
immune activation and lymph node enlargement have been
described earlier [16,36,37,51], they have not been associated with
immune suppression in this way.
The most important consequence of our model is that the
qualitative composition of lymphocyte populations changes
dramatically upon MV infection. Although lymphocyte numbers
in peripheral blood and lymphoid organs appear normal,
depletion of pre-existing specific T- and B-lymphocytes subpop-
ulations provides a direct explanation for the suppression of recall
responses to other pathogens during and after measles. This allows
such pathogens to cause severe disease and in the developing
world leads to the high level of MV-associated mortality. In
addition, MV efficiently replicates in B-lymphocytes, resulting in
follicular exhaustion and disorganization of the germinal centers,
which are essential in actively ongoing humoral immune
responses.
We observed comparable levels of MV-infected cells in TCM,
TEM and Bn, and in parallel observed lymphocyte depletion and
disorganization in B-cell follicles during the acute phase of MV
infection (Figure 3, 9–11 d.p.i.). However, we have also shown
that proliferating cells can be detected in lymphoid tissues as early
as 11 d.p.i., after which time the follicle structure is being restored.
This matches the kinetics of antibody responses in the macaque
model, in that MV-specific IgM and IgG responses are first
detected around 11 d.p.i. and peak at 17 (IgM) and 24 (IgG) d.p.i.
[27,52]. These kinetics fit well with our conclusions from the data
and map well onto the immune suppression model.
It has been described that MV infection can result in transient
remissions of certain autoimmune diseases [53–55]. Our obser-
vations suggest that this can be explained by direct MV infection
of CD150+ lymphocytes, followed by immune-mediated deple-
tion. Similarly, this mechanism could also explain reductions in
HIV-1 loads during acute measles [56,57]: MV infection of
memory CD4+ T-lymphocytes could result in depletion of HIV-
1-infected cells. In certain auto-immune diseases, and in animal
studies in which lymphocyte populations were experimentally
depleted, commensal or opportunistic infectious agents that
would normally be controlled by the immune system have been
shown to cause severe disease [58]. The high incidence of
respiratory and gastro-intestinal complications following measles
[1–3] may therefore be directly related to the observed high
percentages of MV-infection and subsequent lymphocyte deple-
tion in the adenoids, tonsils and gut-associated lymphoid tissue,
which form a first line of defense against inhaled or ingested
pathogens. We conclude that MV infection wipes immunological




Animal experiments were conducted in compliance with
European guidelines (EU directive on animal testing 86/609/
EEC) and Dutch legislation (Experiments on Animals Act, 1997).
The protocols were approved by the independent animal
experimentation ethical review committee DCC in Driebergen,
The Netherlands. Animal welfare was observed on daily basis,
animal handling was performed under light anesthesia using
ketamine and medetomidine. After handling atipamezole was
administered to antagonize the effect of medetomidine. For
experiments involving PBMC from human donors, written
informed consent for research use was obtained by the Sanquin
blood bank.
Animal study design
PBMC and tissues were collected from cynomolgus (Macaca
fascicularis) (n = 35) or rhesus (Macaca mulatta) (n = 5) macaques
included in previously published studies [18,27,30] (n = 26) or
from unpublished infection experiments with rMVIC323EGFP or
rMVKSEGFP (Table S1 and Dataset S1) (n = 14). Macaques were
infected by intra-tracheal inoculation or aerosol inhalation and
euthanized at 2 (n = 3), 3 (n = 3), 4 (n = 3), 5 (n = 4), 7 (n = 9), 9
(n = 8), 11 (n = 6), 13 (n = 2) or 15 (n = 2) d.p.i. Although some of
the experiments had been designed to address different research
questions, the accumulated samples effectively covered all stages of
MV infection in macaques.
Mantoux tests
Four macaques received intra-dermal vaccinations with
460.1 ml of live BCG (NVI, Bilthoven, Netherlands). The animals
received an intra-dermal Mantoux test with old tuberculin (0.1 ml,
25,000 IU/ml, Statens Serum Institut) [59] 3 months post-
vaccination at 7 days pre-MV-infection, or 3 days prior to
necropsy. Skin reactivity was assessed for three consecutive days.
Skin samples from both Mantoux tests (pre- and post-MV
infection) were collected into formalin.
Tuberculin- and MV-specific T-lymphocyte responses
PBMC obtained 7 days pre-infection and during necropsy were
thawed and plated into 96-wells round-bottom plates at 26105
cells per well. Cells were stimulated with either PPD (10 mg/ml),
UV-inactivated MV (10 mg/ml) or live rMVrEdtEGFP [30] (56104
CCID50 in the presence of 10 mg/ml infection-enhancing lipopep-
tide PHCSK4 [60]) for 48 hours in triplicate. IFN-c concentra-
tions were measured in supernatants by ELISA (U-CyTech
Biosciences).
Leukopenia
After each blood collection, total WBC counts were obtained
using an automated counter (Sysmex pocH-100iV). To address
measles-induced leukopenia in these animals, mean WBC counts
were determined on 0 (n= 31), 1 (n = 6), 2 (n = 20), 3 (n = 17), 4
(n = 18), 5 (n = 11), 6 (n = 20), 7 (n = 10), 8 (n = 6), 9 (n = 12), 11
(n = 8) and 13 (n= 2) d.p.i. Different animals were included at each
time-point.
Necropsy
Animals were euthanized by exsanguination under ketamine
anesthesia. For the purpose of detecting EGFP fluorescence, a
lamp was custom-made containing six 5-volt LEDs (Luxeon
Lumileds, lambertian, cyan, peak emission 490–495 nm) mounted
with D480/40 bandpass filters (Chroma) in a frame that allowed
decontamination with 70% (v/v) alcohol or fumigation with
formaldehyde. Emitted fluorescence was visualized through the
amber cover of a UV transilluminator normally used for screening
DNA gels. Photographs were made using a Nikon D80 digital SLR
camera. Lymphoid tissues were collected in buffered formalin for
immunohistochemistry or PBS for preparation of single cell
suspensions, which were used directly for flow cytometry.
Flow cytometry
T-lymphocytes were subdivided into Tn, TCM and TEM
populations (Figure S1) by staining with CD3PerCP (BD Bioscienc-
es, clone SP34-2), CD4V450 (BD Biosciences, clone L200),
CD8AmCyan (BD Biosciences, clone SK1), CD45RAPE-Cy7 (BD
Biosciences, clone L48) and CCR7APC (R&D Systems, clone
150503). The APC signal was enhanced using an APC-FASER
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Kit (Miltenyi Biotec). B-lymphocytes were subdivided into Bn and
BM populations (Figure S1) by staining with CD20PE-Cy7 (BD
Biosciences, clone L27), HLA-DRPacific Blue (Biolegend, clone
L243), CD27APC (eBioscience, clone O323) and a combination of
IgDBiotin (Southern Biotech, goat polyclonal) and streptavidinPerCP
(BD Biosciences). CD150 expression was determined by staining
with CD150FITC (AbD Serotec, clone A12). The infection
percentages within the populations were determined by detection
of EGFP. All flow cytometry was performed on a FACS Canto II
(BD Biosciences).
Histological and immunohistochemical analysis
H&E staining was performed to evaluate histological changes.
Immunohistochemical staining was performed using a fully
automated BondMax immunostainer with a polymer-based
peroxidase detection system. MV-infected cells were detected
using a polyclonal rabbit antibody to EGFP (Invitrogen). Similar
stainings were performed with the following monoclonal antibod-
ies: T-lymphocyte marker CD3 (DAKO, clone F7.2.38),
B-lymphocyte marker CD20 (DAKO, clone L26), proliferation
marker Ki67 (DAKO, clone MIB1) and apoptosis marker cleaved
caspase 3 (Cell Signaling, clone 5A1E). Glass slides were scanned
with a 40X/0.75 Olympus UPlan FLN objective on an Aperio
Scanscope CS-O SS5200 equipped with Spectrum Plus. An
Aperio Positive Pixel Count Algorithm was applies to quantify and
therefore standardize the intensity of stains present to produce
optimal discrimination between immunoperoxidase diaminoben-
zidine (DAB) tetrahydrochloride reactions and hematoxylin
stained nuclei. Scanners are kept at ambient temperature in a
temperature-controlled area to eliminate loss of performance due
to overheating.
Susceptibility of lymphocyte subsets to infection
PBMC from healthy human or macaque donors were sorted
into pure CD4+ or CD8+ naive (CD45RA+) and memory
(CD45RA2) T-lymphocyte populations on basis of CD45RA
expression. Unsorted or sorted PBMC from humans or macaques
were infected by co-culture with low numbers (1:1000) of
autologous MV-infected B-LCL or BAL cells (infected with cell-
free rMVKSEGFP at an MOI of 1 for 48 hours), respectively. After
two days of co-culture infection percentages in the different subsets
were determined by flow cytometry.
Statistical analysis
Differences between percentages infected cells or CD150
expression were tested by the non-parametric Wilcoxon rank test
using SPSS software.
Supporting Information
Dataset S1 Virus isolation data from BAL cells and
PBMC of macaques included in this study. Small-volume
EDTA blood samples were collected in Vacuette tubes. PBMC
were isolated by density gradient centrifugation, resuspended in
culture medium and used for virus isolation. BAL was performed
by intra-tracheal infusion of 10 ml PBS through a flexible catheter
and immediate recovery. Recovered BAL cells were resuspended
in culture medium, counted, and used directly for virus isolation.
Isolation of MV was performed on Vero-CD150 cells using an
infectious center assay. Virus isolations were monitored by UV
microscopy for EGFP fluorescence for 3 to 6 days. Results are
expressed as the number of MV-infected cells per 106 total cells. In
different animal experiments, BAL and PBMC samples were
collected on different time points after MV infection. Available
data per time point were used to calculate the median virus loads,
which are shown as green and red area curves for BAL cells and
PBMC, respectively. Median virus loads determined in BAL cells
or PBMC peaked 9 d.p.i, and virus loads were higher in BAL cells
than in PBMC. In addition to the median virus loads, each plot
shows the virus isolation data obtained for one individual animal;
animals are numbered according to the first column of Table S1.
The green circles and red triangles show the virus loads in BAL
cells and PBMC, respectively. These data are included to provide
background information on the level of individual variation
between outbred non-SPF animals of different species and infected
with different virus strains.
(DOC)
Figure S1 Gating strategy used to distinguish between
different T- and B-lymphocyte subsets. As a first step, the
lymphocyte population was gated on basis of forward and side scatter
(FSC and SSC, respectively). (A) T-lymphocyte subpopulations were
subsequently detected on basis of expression of CD3 and CD4 or
CD8, and identified as naive T-lymphocytes (Tn, CD45RA+), central
memory T-lymphocytes (TCM, CD45RA2CCR7+) or effector
memory T-lymphocytes (TEM, CD45RA2CCR72). The monoclo-
nal antibodies used (see materials and methods for clone numbers)
cross-react with rhesus and cynomolgus macaque antigens (nhprea-
gentsbidmc.harvard.edu/), and identified similar lymphocyte popu-
lations as previously described for human T-lymphocytes. (B)
B-lymphocytes were detected on basis of expression of CD20 and
HLA-DR, and identified as naive B-lymphocytes (Bn, CD272IgD+)
or memory B-lymphocytes (BM, CD27+IgD2) as previously
described. EGFP+ cells were gated to determine the level of MV
infection within each lymphocyte subset. In some cases cells
expressing high levels of EGFP were found to run ‘‘off-scale’’ (see
upper right plot), but these events could be included in the analysis of
the percentage EGFP+ cells.
(TIF)
Figure S2 Dual immunofluorescence staining of lym-
phoid tissues obtained from macaques euthanized
7 d.p.i. (A–C) Large numbers of multinucleated syncytia were
observed in the B-cell follicles and were stained for EGFP (green)
as a marker of MV infection. Double stains were performed with a
B-lymphocyte marker (CD20, red, A), a T-lymphocyte marker
(CD3, red, B) or a macrophage/DC marker (CD11c, red, C) and
DAPI was used to counterstain the nuclei (blue). Left panels only
show the red and blue channels, right panels show the combined
red, blue and green channels. Multi-nucleated giant cells were
mainly of B-lymphocyte origin (panel A), and the infection was
associated with significant cytopathic effects in lymphoid tissues.
(TIF)
Figure S3 Macroscopic detection of EGFP at BCG intra-
dermal injection sites (indicated by arrows). (A) Corre-
sponding normal and (B) fluorescent macroscopic photographs of
BGC-injection sites. To study MV infection of pre-existing specific
memory lymphocytes, four macaques were vaccinated intra-
dermally with BCG three months prior to MV infection.
Vaccination with this live-attenuated bacterial vaccine resulted
in macroscopically detectable local inflammatory responses, which
remained detectable for several weeks post-vaccination. After MV
infection, EGFP fluorescence was observed macroscopically in the
skin at the BCG vaccination sites 9 d.p.i. This was due to the
presence of EGFP+ lymphocytes (not shown), suggesting that the
virus targeted the BCG-specific tissue-resident memory T-
lymphocytes. We have previously described the presence of MV-
infected aggregates of lymphoid cells in the skin of macaques [27],
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but were unable to determine the answer to the ‘‘chicken or egg’’
question: were these cells present in the skin before MV infection
and subsequently targeted by the virus, or did they infiltrate into
the skin after MV infection? The observed infection of
lymphocytes in the skin at the location where the animals had
been intra-dermally immunized with BCG three months earlier
strongly suggests that these lymphocytes were present in the skin
and subsequently targeted by the virus.
(TIF)
Figure S4 Immunohistochemical staining of lymphoid
tissues obtained from macaques euthanized between 5
and 15 d.p.i. Apoptotic cells were visualized indirectly using
monoclonal antibody against CC3 and DAB-detection. The same
animals and lymphoid tissues used in Figure 4 were analyzed and
panels shown are representative for the tissues that have been
examined. The same B-cell follicle is shown at 610 and 620
magnification. The bar below the photomicrographs of the CC3
staining indicates the relative level of apoptosis, as was done for
MV-infection, B-cell depletion, T-cell depletion and proliferation
in Figure 4. Note that there was no change in the numbers of
apoptotic cells within B-cell follicles during the time-course of MV
infection. The green and red bars at the bottom indicate viremia
and rash, and correspond to the bars in Figure 5B. Examples of
CC3-positive cells are indicated by arrows in the lower left panel at
5 d.p.i. These stainings show that the depletion of B-cell follicles is
not caused by apoptosis of infected cells.
(TIF)
Table S1 Overview of animals included in this study. 1
Animal numbering for this manuscript, animals are ordered
according to time point of necropsy; 2 Original animal number as
described in previous manuscripts; 3 F = female, M=male, N= sex
not recorded; 4 C= cynomolgus monkey (Macaca fascicularis),
R= rhesus monkey (Macaca mulatta); 5 Age range, in months; 6
For description of viruses see references under 10; 7 Aerosol = in-
halation of nebulized virus via a facemask, IT= intra-tracheal
inoculation of the virus diluted in 5 ml phosphate buffered saline
(PBS), for description of devices and methods see references under
10; 8 For aerosol administration higher doses were used than for IT
administration, as it was estimated that approximately 1% of the
nebulized dose would be inhaled into the lungs; 9 Time point of
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